Sanford Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$956K Hold
2,343
0.23% 59
2022
Q3
$763K Hold
2,343
0.22% 54
2022
Q2
$822K Buy
2,343
+473
+25% +$193K 0.23% 50
2022
Q1
$1.02M Hold
1,870
0.28% 38
2021
Q4
$1.23M Buy
1,870
+70
+4% +$43.9K 0.28% 35
2021
Q3
$1.12M Hold
1,800
0.28% 36
2021
Q2
$1.14M Hold
1,800
0.29% 36
2021
Q1
$881K Hold
1,800
0.25% 39
2020
Q4
$900K Buy
+1,800
New +$805K 0.29% 36

Other funds holding IDXX

Sanford Advisory Services's IDXX Position: Q4 2022 in Review

Sanford Advisory Services held its Idexx Laboratories (IDXX) position steady in Q4 2022 at 2,343 shares worth $956K. The position accounts for 0.23% of the portfolio, ranked #59.

Sanford Advisory Services first reported a position in IDXX in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.23M in Q4 2021. 1,000 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Sanford Advisory Services held 2,343 shares of Idexx Laboratories worth $956K as of Q4 2022.
  • Sanford Advisory Services left its Idexx Laboratories share count unchanged in Q4 2022.
  • Idexx Laboratories made up 0.23% of Sanford Advisory Services's portfolio in Q4 2022, its #59 holding.
  • Sanford Advisory Services first reported a position in Idexx Laboratories in Q4 2020 and has held it in 9 quarters since.
  • Sanford Advisory Services's Idexx Laboratories position peaked at $1.23M in Q4 2021.
  • 1,000 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Sanford Advisory Services's 13F filing for Q4 2022, filed 8 Feb 2023.